Challenge Competition: Improving Remote Monitoring of Pregnancy, 44818-44820 [2017-20539]

Download as PDF 44818 Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices Court of Federal Claims No: 17–1159V 82. Sandra Blevins, New York, New York Court of Federal Claims No: 17–1161V 83. Michele Harding on behalf of W. J. H., Madison, Wisconsin Court of Federal Claims No: 17–1164V 84. Jody Larsen, Seattle, Washington Court of Federal Claims No: 17–1165V 85. Alexis Garner on behalf of K. T. G., Hyattsville, Maryland Court of Federal Claims No: 17–1166V 86. Elvira Cruz, Englewood, New Jersey Court of Federal Claims No: 17–1167V 87. Rasheedah Smith, Lawrenceville, Georgia Court of Federal Claims No: 17–1169V 88. Carol Clark, Boston, Massachusetts Court of Federal Claims No: 17–1170V 89. Lesa Marie Bowman-Harris, Salem, Oregon Court of Federal Claims No: 17–1172V 90. Jennifer Claypool, Dayton, Nevada Court of Federal Claims No: 17–1176V 91. Theresa Anderson, White Plains, New York Court of Federal Claims No: 17–1178V 92. Maureen C. Clavio, Orland Park, Illinois Court of Federal Claims No: 17–1179V 93. Ellen Honea, Beverly Hills, California Court of Federal Claims No: 17–1180V 94. Jared Sipes, Jacksonville, North Carolina Court of Federal Claims No: 17–1181V [FR Doc. 2017–20540 Filed 9–25–17; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Challenge Competition: Improving Remote Monitoring of Pregnancy Health Resources and Services Administration, Department of Health and Human Services. ACTION: Notice. AGENCY: The Health Resources and Services Administration’s (HRSA’s) Maternal and Child Health Bureau (MCHB) announces a prize competition to support the development and testing of low-cost, scalable technology-based innovations to improve the ability of prenatal care providers to monitor the health and wellbeing of pregnant women remotely, especially women who live in rural and medicallyunderserved areas who have limited access to on-site prenatal care. The statutory authority for this challenge competition is Section 105 of SUMMARY: VerDate Sep<11>2014 18:28 Sep 25, 2017 Jkt 241001 the America COMPETES Reauthorization Act of 2010. This challenge, structured in three phases, will reach a diverse population of innovators and problem solvers including families, coders, public health experts, community leaders, individuals affiliated with academic institutions, research and development communities in the private sector, and others. All submissions will be evaluated; separate prizes will be awarded for each of the three phases below. Phase 1: Design Phase 2: Development and Small Scale Testing Phase 3: Scaling Estimated dates for each phase are as follows: Phase 1: Effective on January 2, 2018 Phase 1 Submission Period Ends: January 31, 2018, 11:59 p.m. ET Phase 1 Judging Period: February 1– February 28, 2018 Phase 1 Winners Announced: March 12, 2018 Phase 2 Begins: March 13, 2018 Phase 2 Submission Period Ends: July 11, 2018 Phase 2 Judging Period: July 12–August 12, 2018 Phase 2 Winners Announced: August 20, 2018 Phase 3 Begins: August 21, 2018 Phase 3 Submission Period Ends: February 21, 2019 Phase 3 Winner Announced: March 1, 2019 FOR FURTHER INFORMATION CONTACT: Jessie Buerlein, MSW, Office of Policy and Planning, MCHB, JBuerlein@ hrsa.gov, (301) 443–8931, or James Resnick, Office of the Associate Administrator, MCHB, JResnick@ hrsa.gov, (301) 443–3222. SUPPLEMENTARY INFORMATION: On January 4, 2011, the America COMPETES Reauthorization Act of 2010 was signed into law allowing the use of challenges and prize competitions increasing agencies’ ability to promote and harness innovation. Competitions run by the federal government result in a number of benefits to the public, including the following: (a) Increasing the number and diversity of the individuals, teams, and organizations that are addressing a particular problem or challenge of national significance; (b) Improving the skills of the participants in the competition; and (c) Directing attention to new market opportunities and stimulating private sector investment. Subject of Challenge Competition In recent years, technological advances have improved the ability of PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 healthcare providers to monitor their patients from afar. For example, wearable biosensors provide for the remote monitoring of patients, athletes, premature infants, children, psychiatric patients, people who need long-term care, the elderly, and people in rural and medically underserved areas. Telemedicine is improving access for patients, while smartphone apps are improving patients’ ability for self-care. At the same time, recent scientific advances around developmental origins of health and disease point to the important role that environmental exposures, nutrition, and stress play in maternal health and fetal programming. Remote, real-time, and more continuous monitoring of harmful environmental exposures, nutritional intake and energy expenditure, and stress and sleep, along with blood pressure, proteinuria, blood glucose, and fetal heart rate, has the potential to improve prenatal care quality and pregnancy outcomes while reducing healthcare costs. Recent trends in hospital closures in rural America also increase the need for technological innovations that support remote monitoring of pregnant women. Between 2004 and 2014, 179 rural counties (9 percent of all rural counties) lost access to in-county hospital obstetric services, and the percent of all rural counties in the U.S. that lacked hospital obstetric services increased from 45 to 54 percent, due to hospital and obstetric-unit closures.1 Many lowincome women, in both rural and urban communities, do not access prenatal care. Fully conflicting priorities such as work, childcare, and transportation make it difficult to make the approximately 15 visits to their provider’s office, which include critical medical assessments and instructions about self-care. This challenge is designed to make technology work for pregnant women, increase access, improve communications (between patients and providers and across providers), and empower pregnant women to take better care of themselves. This challenge will support the development and testing of low-cost, scalable technology-based innovations to improve the ability of prenatal care providers to monitor the health and wellbeing of pregnant women from afar (e.g., in their homes); utilizing technology to empower patients and providers with more complete and upto-date information. Key design features of the innovations should include: 1 http://rhrc.umn.edu/wp-content/files_mf/ 1491501904UMRHRCOBclosuresPolicyBrief.pdf. E:\FR\FM\26SEN1.SGM 26SEN1 Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices • The innovation is low-cost to families and scalable; • The innovation is safe, accurate, and effective; • The innovation supports remote, real-time, and more continuous monitoring and early detection; • The innovation improves communication between patients and providers; • The innovation improves patientcenteredness of prenatal care; • What gets monitored is grounded in science (e.g., developmental origins of health and disease); and • The innovation empowers patients to use their own health data to improve behaviors. Eligibility Rules for Participating in the Competition To be eligible to win a prize under this challenge, an individual or entity— (1) Shall have registered to participate in the competition under the rules promulgated by HRSA and the U.S. Department of Health and Human Services (HHS). (2) Shall have complied with all the requirements under this section. (3) In the case of a private entity, shall be incorporated in and maintain a primary place of business in the United States, and in the case of an individual, whether participating singly or in a group, shall be a citizen or permanent resident of the United States. (4) May not be a federal entity or federal employee acting within the scope of their employment. (5) Shall not be an HHS employee working on their applications or submissions during assigned duty hours. (6) May not be employees of HRSA or any other company, organization, or individual involved with the design, production, execution, judging, or distribution of the Challenge and their immediate family (i.e., spouse, parents and step-parents, siblings and stepsiblings, and children and stepchildren) and household members (i.e., people who share the same residence at least 3 months out of the year). (7) In the case of a federal grantee, may not use federal funds to develop COMPETES Act challenge applications unless consistent with the purpose of their grant award. (8) In the case of a federal contractor, may not use federal funds from a contract to develop COMPETES Act challenge applications or to fund efforts in support of a COMPETES Act challenge submission. (9) Shall not be deemed ineligible because the individual or entity used federal facilities or consulted with VerDate Sep<11>2014 18:28 Sep 25, 2017 Jkt 241001 federal employees during a competition if the facilities and employees are made equitably available to all individuals and entities participating in the competition. (10) Must agree to assume any and all risks and waive claims against the federal government and its related entities, except in the case of willful misconduct, for any injury, death, damage, or loss of property, revenue, or profits, whether direct, indirect, or consequential, arising from the participation in this prize contest, whether the injury, death, damage, or loss arises through negligence or otherwise. (11) Must also agree to indemnify the federal government against third party claims for damages arising from or related to competition activities. (12) Shall not be currently on the Excluded Parties List (https:// www.epls.gov/). Submission Requirements The Challenge has three phases. Phase 1—Design The first stage of the prize competition aims to attract a large set of ideas and innovators. The target product of the first stage will be the conceptualization of the most promising innovations to improve the ability of prenatal care providers to monitor the health and wellbeing of pregnant women remotely, especially women who live in rural and medically underserved areas who have limited access to on-site prenatal care. The submissions should aim to demonstrate that the proposed intervention will be accessible across diverse backgrounds and easily implemented by users. The Phase 1 Submission shall include: 1. A comprehensive description of the proposed intervention in five pages or less, including: a. A one-paragraph executive summary that clearly states the question to be solved; b. Background information linking the evidence to support the intervention; c. A descriptive analysis of how the applicant arrived at their idea; d. Descriptions of the methods and technologies involved in implementation of the intervention; and e. An assessment describing the applicant’s ability to execute the proposed solution in Phase 2 and 3. Phase 2—Development and Small Scale Testing The winners of Phase 1 of the prize competition will then advance to a PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 44819 second stage focused on prototyping the intervention, and testing the effectiveness of the intervention. Using support from the Phase 1 prize funding, intervention developers will test the efficacy of their models to show that the proposed intervention demonstrates an impact on the outcomes of interest for providers and pregnant women. The applicants should demonstrate both the evidence base for the intervention and its usability. Mentors will be available to help participants design appropriate testing methodologies and learn more about the evidence base. Phase 3—Scaling The winners of Phase 2 will move to the final phase of the incentive prize, which will involve testing the most promising models at greater scale through rollout at the program or community level. This will test the scalability of the device at low-cost, the feasibility of implementation, and the impact on the intended outcomes. Registration Process for Participants Participants will be able to register and submit an entry at the Improving Remote Monitoring of Pregnancy Challenge Web site. Participants can find out more information at https:// www.challenge.gov/list/. Prizes • Total: $375,000 in Prizes Æ Phase 1: 7–10 winners; up to a total of $100,000 in prizes Æ Phase 2: 3–5 winners; up to a total of $125,000 in prizes Æ Phase 3: 1 winner; up to a total of $150,000 prize Payment of the Prizes Prize payments will be paid by a contractor. Phase 1 winners may be expected to use a portion of the prize money for travel and lodging to attend a 2-day meeting in Washington, DC, to demonstrate their innovation to the judges. Prizes awarded under this competition will be paid by electronic funds transfer and may be subject to Federal income taxes. HHS will comply with the Internal Revenue Service withholding and reporting requirements, where applicable. Basis for Winner Selection A review panel composed of HHS employees and experts will judge challenge entries in compliance with the requirements of the America COMPETES Act and HHS judging guidelines: http://www.hhs.gov/idealab/ wp-content/uploads/2014/04/HHSCOMPETITION-JUDGINGGUIDELINES.pdf. E:\FR\FM\26SEN1.SGM 26SEN1 44820 Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices The review panel will make selections based upon the following criteria: Phase 1 Accessibility • Is the proposed intervention easily utilized by families of diverse economic, social, and cultural backgrounds? Is it functional across disciplines/users? Measurability • How easily will the proposed intervention be evaluated in order to determine its efficacy (in both lab testing and in the real world)? Is the proposed intervention measurable among various audiences? Sustainability • Does the proposed intervention compel users to utilize the technology often and/or for long periods of time? Does it fit into daily life? Is it fun to use? Impact • Does the applicant present a theory or explanation of how the proposed intervention would result in concrete change? Phase 2 Impact • How did the intervention impact outcomes for providers and patients? What did data show? Evidence Base • Is the intervention grounded in existing science related to improving health care and related services for pregnant women? Sustainability • Was the intervention compelling to users and did it encourage users to use the technology often? Did users want to continuously engage with the technology? Implementation • How feasible is the intervention? How much support for implementation will the intervention require (estimated financial and time commitment)? Phase 3 Impact • How effective was the intervention when implemented at scale? Did the impacts on users from Phase 2 remain consistent? Scalability • How costly was the intervention in a real-world setting? How likely are cost efficiencies for program delivery at greater scale? Can the technology be used in existing platforms? Additional Information General Conditions: • HRSA reserves the right to cancel, suspend, and/or modify the contest, or any part of it, for any reason, at HRSA’s sole discretion. • The interventions submitted across all phases should not use the HHS or HRSA logos or official seals in the submission, and must not claim endorsement. Intellectual Property • Each entrant retains full ownership and title in and to their submission. Entrants expressly reserve all intellectual property rights not expressly granted under the challenge agreement. • By participating in the challenge, each entrant hereby irrevocably grants to HRSA a limited, non-exclusive, royalty-free, worldwide license and right to reproduce, publically perform, publically display, and use the submission for internal HHS business and to the extent necessary to administer the challenge, and to publically perform and publically display the submission, including, without limitation, for advertising and promotional purposes relating to the challenge. • Record Retention and FOIA: All materials submitted to HRSA as part of a submission become HRSA records and cannot be returned. Any confidential commercial information contained in a submission should be designated at the time of submission. Participants will be notified of any Freedom of Information Act requests for their submissions in accordance with 45 CFR 5.65. Dated: September 19, 2017. George Sigounas, Administrator. [FR Doc. 2017–20539 Filed 9–25–17; 8:45 am] BILLING CODE 4165–15–P Implementation • How feasible was the intervention on a larger scale? How much support for implementation did the model require (financial and time commitment)? How challenging was the actual program implementation? VerDate Sep<11>2014 18:28 Sep 25, 2017 Jkt 241001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Notice of Non-Competitive, Supplemental Funding Award for Ryan White HIV/AIDS Program, Special Projects of National Significance Health Resources and Services Administration (HRSA), HHS. ACTION: Notice. AGENCY: This non-competitive award will provide Secretary’s Minority AIDS Initiative Fund (SMAIF) supplemental funding to the Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color—Evaluation and Technical Assistance Center (ETAC), RAND Corporation. This supplemental funding will allow RAND Corporation to provide evaluation and technical assistance to cooperative agreement recipients and subrecipient clinical sites under HRSA–17–047 Curing Hepatitis C among People of Color Living with HIV. SUPPLEMENTARY INFORMATION: Intended Recipient of the Award: RAND Corporation (U90HA30519). Amount of Non-Competitive Award: Up to $250,000 per year for 3 years (pending availability of future year funding). Period of Funding: September 30, 2017, through September 29, 2020. CFDA Number: No. 93.928. Authority: The Consolidated Appropriations Act, 2017 (Pub. L. 115– 31), Division H, Title II. Justification: In fiscal year (FY) 2016, the SMAIF Curing Hepatitis C among People of Color Living with HIV initiative was launched through three funding opportunities: (1) Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Co-infected People of Color— Jurisdictional Sites (HRSA–16–189) and (2) Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color—State Health Departments Coordinating Center (HRSA–16–195) to provide HIV primary medical care to low income, uninsured, and underserved people living with both HIV and hepatitis C virus (HCV); and (3) Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color—ETAC (HRSA–16–188) to provide evaluation and technical assistance to the funded sites. In FY17, HRSA–17–047 was announced to improve HCV prevention and care; improve coordination to linkage and retention in care; and enhance capacity of health department SUMMARY: E:\FR\FM\26SEN1.SGM 26SEN1

Agencies

[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Pages 44818-44820]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20539]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Challenge Competition: Improving Remote Monitoring of Pregnancy

AGENCY: Health Resources and Services Administration, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration's (HRSA's) 
Maternal and Child Health Bureau (MCHB) announces a prize competition 
to support the development and testing of low-cost, scalable 
technology-based innovations to improve the ability of prenatal care 
providers to monitor the health and wellbeing of pregnant women 
remotely, especially women who live in rural and medically-underserved 
areas who have limited access to on-site prenatal care.
    The statutory authority for this challenge competition is Section 
105 of the America COMPETES Reauthorization Act of 2010.
    This challenge, structured in three phases, will reach a diverse 
population of innovators and problem solvers including families, 
coders, public health experts, community leaders, individuals 
affiliated with academic institutions, research and development 
communities in the private sector, and others.
    All submissions will be evaluated; separate prizes will be awarded 
for each of the three phases below.

Phase 1: Design
Phase 2: Development and Small Scale Testing
Phase 3: Scaling

    Estimated dates for each phase are as follows:

Phase 1: Effective on January 2, 2018
Phase 1 Submission Period Ends: January 31, 2018, 11:59 p.m. ET
Phase 1 Judging Period: February 1-February 28, 2018
Phase 1 Winners Announced: March 12, 2018
Phase 2 Begins: March 13, 2018
Phase 2 Submission Period Ends: July 11, 2018
Phase 2 Judging Period: July 12-August 12, 2018
Phase 2 Winners Announced: August 20, 2018
Phase 3 Begins: August 21, 2018
Phase 3 Submission Period Ends: February 21, 2019
Phase 3 Winner Announced: March 1, 2019

FOR FURTHER INFORMATION CONTACT: Jessie Buerlein, MSW, Office of Policy 
and Planning, MCHB, JBuerlein@hrsa.gov, (301) 443-8931, or James 
Resnick, Office of the Associate Administrator, MCHB, 
JResnick@hrsa.gov, (301) 443-3222.

SUPPLEMENTARY INFORMATION: On January 4, 2011, the America COMPETES 
Reauthorization Act of 2010 was signed into law allowing the use of 
challenges and prize competitions increasing agencies' ability to 
promote and harness innovation. Competitions run by the federal 
government result in a number of benefits to the public, including the 
following:
    (a) Increasing the number and diversity of the individuals, teams, 
and organizations that are addressing a particular problem or challenge 
of national significance;
    (b) Improving the skills of the participants in the competition; 
and
    (c) Directing attention to new market opportunities and stimulating 
private sector investment.

Subject of Challenge Competition

    In recent years, technological advances have improved the ability 
of healthcare providers to monitor their patients from afar. For 
example, wearable biosensors provide for the remote monitoring of 
patients, athletes, premature infants, children, psychiatric patients, 
people who need long-term care, the elderly, and people in rural and 
medically underserved areas. Telemedicine is improving access for 
patients, while smartphone apps are improving patients' ability for 
self-care.
    At the same time, recent scientific advances around developmental 
origins of health and disease point to the important role that 
environmental exposures, nutrition, and stress play in maternal health 
and fetal programming. Remote, real-time, and more continuous 
monitoring of harmful environmental exposures, nutritional intake and 
energy expenditure, and stress and sleep, along with blood pressure, 
proteinuria, blood glucose, and fetal heart rate, has the potential to 
improve prenatal care quality and pregnancy outcomes while reducing 
healthcare costs.
    Recent trends in hospital closures in rural America also increase 
the need for technological innovations that support remote monitoring 
of pregnant women. Between 2004 and 2014, 179 rural counties (9 percent 
of all rural counties) lost access to in-county hospital obstetric 
services, and the percent of all rural counties in the U.S. that lacked 
hospital obstetric services increased from 45 to 54 percent, due to 
hospital and obstetric-unit closures.\1\ Many low-income women, in both 
rural and urban communities, do not access prenatal care. Fully 
conflicting priorities such as work, childcare, and transportation make 
it difficult to make the approximately 15 visits to their provider's 
office, which include critical medical assessments and instructions 
about self-care. This challenge is designed to make technology work for 
pregnant women, increase access, improve communications (between 
patients and providers and across providers), and empower pregnant 
women to take better care of themselves.
---------------------------------------------------------------------------

    \1\ http://rhrc.umn.edu/wp-content/files_mf/1491501904UMRHRCOBclosuresPolicyBrief.pdf.
---------------------------------------------------------------------------

    This challenge will support the development and testing of low-
cost, scalable technology-based innovations to improve the ability of 
prenatal care providers to monitor the health and wellbeing of pregnant 
women from afar (e.g., in their homes); utilizing technology to empower 
patients and providers with more complete and up-to-date information.
    Key design features of the innovations should include:

[[Page 44819]]

     The innovation is low-cost to families and scalable;
     The innovation is safe, accurate, and effective;
     The innovation supports remote, real-time, and more 
continuous monitoring and early detection;
     The innovation improves communication between patients and 
providers;
     The innovation improves patient-centeredness of prenatal 
care;
     What gets monitored is grounded in science (e.g., 
developmental origins of health and disease); and
     The innovation empowers patients to use their own health 
data to improve behaviors.

Eligibility Rules for Participating in the Competition

    To be eligible to win a prize under this challenge, an individual 
or entity--
    (1) Shall have registered to participate in the competition under 
the rules promulgated by HRSA and the U.S. Department of Health and 
Human Services (HHS).
    (2) Shall have complied with all the requirements under this 
section.
    (3) In the case of a private entity, shall be incorporated in and 
maintain a primary place of business in the United States, and in the 
case of an individual, whether participating singly or in a group, 
shall be a citizen or permanent resident of the United States.
    (4) May not be a federal entity or federal employee acting within 
the scope of their employment.
    (5) Shall not be an HHS employee working on their applications or 
submissions during assigned duty hours.
    (6) May not be employees of HRSA or any other company, 
organization, or individual involved with the design, production, 
execution, judging, or distribution of the Challenge and their 
immediate family (i.e., spouse, parents and step-parents, siblings and 
step-siblings, and children and step-children) and household members 
(i.e., people who share the same residence at least 3 months out of the 
year).
    (7) In the case of a federal grantee, may not use federal funds to 
develop COMPETES Act challenge applications unless consistent with the 
purpose of their grant award.
    (8) In the case of a federal contractor, may not use federal funds 
from a contract to develop COMPETES Act challenge applications or to 
fund efforts in support of a COMPETES Act challenge submission.
    (9) Shall not be deemed ineligible because the individual or entity 
used federal facilities or consulted with federal employees during a 
competition if the facilities and employees are made equitably 
available to all individuals and entities participating in the 
competition.
    (10) Must agree to assume any and all risks and waive claims 
against the federal government and its related entities, except in the 
case of willful misconduct, for any injury, death, damage, or loss of 
property, revenue, or profits, whether direct, indirect, or 
consequential, arising from the participation in this prize contest, 
whether the injury, death, damage, or loss arises through negligence or 
otherwise.
    (11) Must also agree to indemnify the federal government against 
third party claims for damages arising from or related to competition 
activities.
    (12) Shall not be currently on the Excluded Parties List (https://www.epls.gov/).

Submission Requirements

    The Challenge has three phases.

Phase 1--Design

    The first stage of the prize competition aims to attract a large 
set of ideas and innovators. The target product of the first stage will 
be the conceptualization of the most promising innovations to improve 
the ability of prenatal care providers to monitor the health and 
wellbeing of pregnant women remotely, especially women who live in 
rural and medically underserved areas who have limited access to on-
site prenatal care.
    The submissions should aim to demonstrate that the proposed 
intervention will be accessible across diverse backgrounds and easily 
implemented by users.
    The Phase 1 Submission shall include:
    1. A comprehensive description of the proposed intervention in five 
pages or less, including:
    a. A one-paragraph executive summary that clearly states the 
question to be solved;
    b. Background information linking the evidence to support the 
intervention;
    c. A descriptive analysis of how the applicant arrived at their 
idea;
    d. Descriptions of the methods and technologies involved in 
implementation of the intervention; and
    e. An assessment describing the applicant's ability to execute the 
proposed solution in Phase 2 and 3.

Phase 2--Development and Small Scale Testing

    The winners of Phase 1 of the prize competition will then advance 
to a second stage focused on prototyping the intervention, and testing 
the effectiveness of the intervention. Using support from the Phase 1 
prize funding, intervention developers will test the efficacy of their 
models to show that the proposed intervention demonstrates an impact on 
the outcomes of interest for providers and pregnant women. The 
applicants should demonstrate both the evidence base for the 
intervention and its usability. Mentors will be available to help 
participants design appropriate testing methodologies and learn more 
about the evidence base.

Phase 3--Scaling

    The winners of Phase 2 will move to the final phase of the 
incentive prize, which will involve testing the most promising models 
at greater scale through rollout at the program or community level. 
This will test the scalability of the device at low-cost, the 
feasibility of implementation, and the impact on the intended outcomes.

Registration Process for Participants

    Participants will be able to register and submit an entry at the 
Improving Remote Monitoring of Pregnancy Challenge Web site. 
Participants can find out more information at https://www.challenge.gov/list/.

Prizes

 Total: $375,000 in Prizes
    [cir] Phase 1: 7-10 winners; up to a total of $100,000 in prizes
    [cir] Phase 2: 3-5 winners; up to a total of $125,000 in prizes
    [cir] Phase 3: 1 winner; up to a total of $150,000 prize

Payment of the Prizes

    Prize payments will be paid by a contractor. Phase 1 winners may be 
expected to use a portion of the prize money for travel and lodging to 
attend a 2-day meeting in Washington, DC, to demonstrate their 
innovation to the judges.
    Prizes awarded under this competition will be paid by electronic 
funds transfer and may be subject to Federal income taxes. HHS will 
comply with the Internal Revenue Service withholding and reporting 
requirements, where applicable.

Basis for Winner Selection

    A review panel composed of HHS employees and experts will judge 
challenge entries in compliance with the requirements of the America 
COMPETES Act and HHS judging guidelines: http://www.hhs.gov/idealab/wp-content/uploads/2014/04/HHS-COMPETITION-JUDGING-GUIDELINES.pdf.

[[Page 44820]]

    The review panel will make selections based upon the following 
criteria:

Phase 1

Accessibility

     Is the proposed intervention easily utilized by families 
of diverse economic, social, and cultural backgrounds? Is it functional 
across disciplines/users?

Measurability

     How easily will the proposed intervention be evaluated in 
order to determine its efficacy (in both lab testing and in the real 
world)? Is the proposed intervention measurable among various 
audiences?

Sustainability

     Does the proposed intervention compel users to utilize the 
technology often and/or for long periods of time? Does it fit into 
daily life? Is it fun to use?

Impact

     Does the applicant present a theory or explanation of how 
the proposed intervention would result in concrete change?

Phase 2

Impact

     How did the intervention impact outcomes for providers and 
patients? What did data show?

Evidence Base

     Is the intervention grounded in existing science related 
to improving health care and related services for pregnant women?

Sustainability

     Was the intervention compelling to users and did it 
encourage users to use the technology often? Did users want to 
continuously engage with the technology?

Implementation

     How feasible is the intervention? How much support for 
implementation will the intervention require (estimated financial and 
time commitment)?

Phase 3

Impact

     How effective was the intervention when implemented at 
scale? Did the impacts on users from Phase 2 remain consistent?

Implementation

     How feasible was the intervention on a larger scale? How 
much support for implementation did the model require (financial and 
time commitment)? How challenging was the actual program 
implementation?

Scalability

     How costly was the intervention in a real-world setting? 
How likely are cost efficiencies for program delivery at greater scale? 
Can the technology be used in existing platforms?

Additional Information

    General Conditions:
     HRSA reserves the right to cancel, suspend, and/or modify 
the contest, or any part of it, for any reason, at HRSA's sole 
discretion.
     The interventions submitted across all phases should not 
use the HHS or HRSA logos or official seals in the submission, and must 
not claim endorsement.

Intellectual Property

     Each entrant retains full ownership and title in and to 
their submission. Entrants expressly reserve all intellectual property 
rights not expressly granted under the challenge agreement.
     By participating in the challenge, each entrant hereby 
irrevocably grants to HRSA a limited, non-exclusive, royalty-free, 
worldwide license and right to reproduce, publically perform, 
publically display, and use the submission for internal HHS business 
and to the extent necessary to administer the challenge, and to 
publically perform and publically display the submission, including, 
without limitation, for advertising and promotional purposes relating 
to the challenge.
     Record Retention and FOIA: All materials submitted to HRSA 
as part of a submission become HRSA records and cannot be returned. Any 
confidential commercial information contained in a submission should be 
designated at the time of submission. Participants will be notified of 
any Freedom of Information Act requests for their submissions in 
accordance with 45 CFR 5.65.

    Dated: September 19, 2017.
George Sigounas,
Administrator.
[FR Doc. 2017-20539 Filed 9-25-17; 8:45 am]
BILLING CODE 4165-15-P